Celebrating 15 Years of TSR
Offer ending on Thursday, 6 PM!
Fundamental Analysis of Fortis Healthcare Ltd. - Growth / Value Index
FORTIS - Valuation Highlights
Valuation Analysis
Undervalued - Price to Intrinsic Value of 0.337
Book Value in last 3 years is trending up
Price to Earning Ratio is 74.49 and EV to EBITDA is 38.73 suggesting that it is very expensive
Price to Book Ratio of 6.59 suggesting that it is very expensive
Valuation Key Ratios
Ratio | TTM | Latest FY | Yoy Change | MRQ | Screener/ About |
---|---|---|---|---|---|
Price to Earning | 74.17 | 68.07 | 28.45 % | ||
Price to Book | 6.56 | 5.91 | 42.71 % | 6.26 | |
Price to Sales | 7.38 | 6.77 | 47.07 % | ||
Enterprise Value to EBITDA Multiple | 34.92 | 44.04 % |
FORTIS - Profitability Highlights
Profitability Analysis
Piotroski F Score - Excellent Value of 8.0
Annual Net Profit in last 3 years is trending up
EBITDA is continuously increasing for last 3 Years
Tsr Profitability Index - Poor Score of 35.00
Very Low Dividend Yield of 0.130 %
Profitability Key Ratios
Ratio | TTM | Latest FY | Yoy Change | MRQ | Screener/ About |
---|---|---|---|---|---|
Return On Equity | 9.69 | 8.68 | 11.10 % | 2.06 | |
Return On Asset | 5.74 | 5.65 | 25.47 % | 1.34 | |
Net Profit Margin | 9.95 | 9.95 | 14.50 % | 9.16 | |
Operating Profit Margin | 58.54 | 13.08 | 13.52 % | 21.70 | |
EBITDA Margin | 19.81 | 20.12 | 4.89 % | 20.04 |
Highlights
Market Cap | 574938 M |
Enterprise Value | 594609 M |
Price/Book TTM | 6.56 |
Outstanding Share | 754958 K |
Float/ Outstanding Share | 64.76% |
Dividend Yield | 0.130 % |
Share Holding
Guru Numbers
Price/Graham No | 4.61 |
Peter Lynch Ratio | 0.396 |
Piotroski F Score | 8.00 |
Altman Z Score | 8.13 |
Sloan Ratio | 0.0095 |
Peter Lynch Fair Value | 171.25 |
FORTIS - Growth Highlights
Growth Analysis
Annual sales of the company is increased for three years in a row
Quarterly sales in last 5 years is trending up
Steady increase in Total Assets for last 3 Years
Growth Key Fields
Field | TTM | YoY Growth | QoQ Growth |
---|---|---|---|
Revenue | 7782.75 (Cr) | 12.91 % | 4.09 % |
Gross Profit | 3648.26 (Cr) | 34.09 % | 20.61 % |
EBITDA | 1541.89 (Cr) | 18.43 % | 3.19 % |
Net Profit | 774.21 (Cr) | 29.28 % | 25.82 % |
EPS | 10.27 | 29.38 % | NA |
FORTIS - Stability Highlights
Stability Analysis
Tsr Stability Index - Good Score of 71.88
Altman Z Score of 8.16 suggests good Stability
Company financial liquidity has improved
Stability Key Ratios
Ratio | Latest FY | Yoy Change | MRQ | Screener/ About |
---|---|---|---|---|
Debt to Equity Ratio | 0.278 | 133.74 % | 0.252 | |
Cash Ratio | 0.316 | 67.43 % | ||
Quick Ratio | 1.27 | 207.78 % | 0.844 | |
Shareholders Equity | 65.12 | 12.94 % | ||
Debt to EBITDA | 1.58 | 129.65 % |
Historical Valuation Ratios of Fortis Healthcare Ltd.
Historical Valuation Ratios
Loading ...

Historical Profitability Ratios of Fortis Healthcare Ltd.
Historical Profitability Ratios
Loading ...

Historical Efficiency Ratios of Fortis Healthcare Ltd.
Historical Efficiency Ratios
Loading ...

Historical Solvency Ratios of Fortis Healthcare Ltd.
Historical Solvency Ratios
Loading ...
